523 related articles for article (PubMed ID: 31105530)
21. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs.
Michaud SE; Renier G
Diabetes; 2001 Mar; 50(3):660-6. PubMed ID: 11246888
[TBL] [Abstract][Full Text] [Related]
22. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells.
Menendez JA; Vellon L; Lupu R
Med Hypotheses; 2005; 64(5):997-1001. PubMed ID: 15780499
[TBL] [Abstract][Full Text] [Related]
23. Fatty acid signaling in the beta-cell and insulin secretion.
Nolan CJ; Madiraju MS; Delghingaro-Augusto V; Peyot ML; Prentki M
Diabetes; 2006 Dec; 55 Suppl 2():S16-23. PubMed ID: 17130640
[TBL] [Abstract][Full Text] [Related]
24. Nutrigenomics of ω-3 fatty acids: Regulators of the master transcription factors.
Rodríguez-Cruz M; Serna DS
Nutrition; 2017 Sep; 41():90-96. PubMed ID: 28760435
[TBL] [Abstract][Full Text] [Related]
25. Recent developments in lipid emulsions: relevance to intensive care.
Carpentier YA; Simoens C; Siderova V; el Nakadi I; Vanweyenberg V; Eggerickx D; Deckelbaum RJ
Nutrition; 1997 Sep; 13(9 Suppl):73S-78S. PubMed ID: 9290113
[TBL] [Abstract][Full Text] [Related]
26. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose.
Hyder A; Zenhom M; Klapper M; Herrmann J; Schrezenmeir J
Islets; 2010; 2(3):174-84. PubMed ID: 21099311
[TBL] [Abstract][Full Text] [Related]
27. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
28. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.
Maes M; Christophe A; Delanghe J; Altamura C; Neels H; Meltzer HY
Psychiatry Res; 1999 Mar; 85(3):275-91. PubMed ID: 10333380
[TBL] [Abstract][Full Text] [Related]
29. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
Kliewer SA; Lehmann JM; Milburn MV; Willson TM
Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
[TBL] [Abstract][Full Text] [Related]
30. Ligand selectivity of the peroxisome proliferator-activated receptor alpha.
Lin Q; Ruuska SE; Shaw NS; Dong D; Noy N
Biochemistry; 1999 Jan; 38(1):185-90. PubMed ID: 9890897
[TBL] [Abstract][Full Text] [Related]
31. Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases.
Bartoszek A; Moo EV; Binienda A; Fabisiak A; Krajewska JB; Mosińska P; Niewinna K; Tarasiuk A; Martemyanov K; Salaga M; Fichna J
Pharmacol Res; 2020 Feb; 152():104604. PubMed ID: 31846762
[TBL] [Abstract][Full Text] [Related]
32. Understanding Peroxisome Proliferator-Activated Receptors: From the Structure to the Regulatory Actions on Metabolism.
Lamas Bervejillo M; Ferreira AM
Adv Exp Med Biol; 2019; 1127():39-57. PubMed ID: 31140170
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic fatty acid binding protein sensing fatty acids for peroxisome proliferator activated receptor activation.
Wolfrum C
Cell Mol Life Sci; 2007 Oct; 64(19-20):2465-76. PubMed ID: 17876520
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
35. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.
Schroeder F; Petrescu AD; Huang H; Atshaves BP; McIntosh AL; Martin GG; Hostetler HA; Vespa A; Landrock D; Landrock KK; Payne HR; Kier AB
Lipids; 2008 Jan; 43(1):1-17. PubMed ID: 17882463
[TBL] [Abstract][Full Text] [Related]
36. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
Forman BM; Chen J; Evans RM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4312-7. PubMed ID: 9113986
[TBL] [Abstract][Full Text] [Related]
37. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
38. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
Yessoufou A; Wahli W
Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors.
Clarke SD; Thuillier P; Baillie RA; Sha X
Am J Clin Nutr; 1999 Oct; 70(4):566-71. PubMed ID: 10500027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
